Insulet (PODD) Change in Account Payables (2020 - 2026)
Insulet's (PODD) quarterly Change in Account Payables came in at -$31.5 million in Q2 2026, down 187.26% on a YoY basis from $36.1 million in Q2 2025, and down 144.12% quarter-over-quarter from $71.4 million in Q1 2026.
Analysis
Insulet (PODD) Change in Account Payables (2020 - 2026) Analysis & Trends
Insulet (PODD) has reported Change in Account Payables for 7 consecutive years, with -$31.5 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Change in Account Payables fell 187.26% year-over-year to -$31.5 million; the trailing twelve-month figure through Jun 2026 stood at $16.5 million (down 10.33% YoY), and the FY2025 full-year result was $49.2 million, up 2136.36% from the prior year.
- Change in Account Payables fell to -$31.5 million in Q2 2026 per PODD's latest filing, from $71.4 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $71.4 million in Q1 2026 and bottomed at -$52.5 million in Q4 2023.
- Historically, Change in Account Payables has averaged $4.3 million across 5 years, with a median of $4.3 million in 2022.
- The sharpest annual moves came in 2023 and 2025: Change in Account Payables slumped 1131.25% in 2023, then jumped 3911.11% in 2025.
- Over 5 years, Change in Account Payables stood at -$25.7 million in 2022, then tumbled by 104.28% to -$52.5 million in 2023, then soared by 66.1% to -$17.8 million in 2024, then soared by 232.58% to $23.6 million in 2025, then plunged by 233.47% to -$31.5 million in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods registered -$31.5 million, $71.4 million, and $23.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.76 Bn | 175.16 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn | -52.50 Mn |
| 3 | Medtronic | 117.20 Bn | 108.39 Bn | 6.34 Bn | - |
| 4 | Stryker | 104.01 Bn | 100.53 Bn | 4.50 Bn | 71.00 Mn |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.80 Bn | 45.55 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.03 Bn | 31.58 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | - |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | 4.30 Mn |
| 10 | Insulet | 9.35 Bn | 8.82 Bn | 562.60 Mn | -31.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -31.50 Mn |
| Mar 31, 2026 | 71.40 Mn |
| Dec 31, 2025 | 23.60 Mn |
| Sep 30, 2025 | -47.00 Mn |
| Jun 30, 2025 | 36.10 Mn |
| Mar 31, 2025 | 36.50 Mn |
| Dec 31, 2024 | -17.80 Mn |
| Sep 30, 2024 | -36.40 Mn |
| Jun 30, 2024 | 900,000.00 |
| Mar 31, 2024 | 55.50 Mn |
| Dec 31, 2023 | -52.50 Mn |
| Sep 30, 2023 | -33.00 Mn |
| Jun 30, 2023 | 23.00 Mn |
| Mar 31, 2023 | 51.50 Mn |
| Dec 31, 2022 | -25.70 Mn |
| Sep 30, 2022 | 3.20 Mn |
| Jun 30, 2022 | 5.40 Mn |
| Mar 31, 2022 | 14.70 Mn |
| Dec 31, 2021 | -21.60 Mn |
| Sep 30, 2021 | 10.40 Mn |